Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals, 27131 [2019-12278]

Download as PDF 27131 Federal Register / Vol. 84, No. 112 / Tuesday, June 11, 2019 / Notices 0002. Send one self-addressed adhesive label to assist that office in processing your requests. See the SUPPLEMENTARY INFORMATION section for electronic access to the draft guidance document. Sau L. Lee, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 2130, Silver Spring, MD 20993–0002, 301–796–2905. FOR FURTHER INFORMATION CONTACT: SUMMARY: Persons with access to the internet may obtain the draft guidance at either https://www.fda.gov/drugs/guidancecompliance-regulatory-information/ guidances-drugs or https:// www.regulations.gov. FOR FURTHER INFORMATION CONTACT: Dated: June 6, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019–12292 Filed 6–10–19; 8:45 am] BILLING CODE 4164–01–P SUPPLEMENTARY INFORMATION: The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. II. Electronic Access Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A–12M, 11601 Landsdown St., North Bethesda, MD 20852, 301–796–7726, PRAStaff@ fda.hhs.gov. The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at http://www.reginfo.gov/public/do/ PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of February 27, 2019, FDA published a notice with a 90-day comment period to request comments on the draft guidance for industry entitled ‘‘Quality Considerations for Continuous Manufacturing.’’ FDA is reopening the comment period until August 12, 2019. The Agency believes that an additional 60 days will allow adequate time for interested persons to submit comments without compromising the timely publication of the final version of the guidance. DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA–2018–N–0215; FDA– 2012–N–0248; FDA–2015–N–2126; FDA– 2012–N–0280; FDA–2012–N–1093; FDA– 2018–N–4130; and FDA–2011–N–0143] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB OMB control No. Title of collection Healthcare Professional Survey of Professional Prescription Drug Promotion ...................................................... Formal Dispute Resolutions; Appeals Above the Division Level ............................................................................ Food and Drug Administration’s Research and Evaluation Survey for the Public Education Campaign on Tobacco Among LGBT (RESPECT) ........................................................................................................................ Financial Disclosure by Clinical Investigators ......................................................................................................... Food Additive Petitions and Investigational Food Additive Exemptions ................................................................. Recordkeeping Requirements for Microbiological Testing and Corrective Measures for Bottled Water ............... Foreign Supplier Verification Programs for Importers of Food for Humans and Animals ...................................... Dated: June 6, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019–12278 Filed 6–10–19; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration khammond on DSKBBV9HB2PROD with NOTICES 17:36 Jun 10, 2019 Jkt 247001 To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, Fax: 202– 395–7285, or emailed to oira_ submission@omb.eop.gov. All ADDRESSES: Food and Drug Administration, VerDate Sep<11>2014 The Food and Drug Administration (FDA, the Agency, or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. SUMMARY: Fax written comments on the collection of information by July 11, 2019. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Mitigation Strategies To Protect Food Against Intentional Adulteration HHS. Notice. DATES: [Docket No. FDA–2013–N–1425] AGENCY: ACTION: PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 Date approval expires 0910–0869 0910–0430 4/30/2020 3/31/2022 0910–0808 0910–0396 0910–0546 0910–0658 0910–0752 3/31/2022 4/30/2022 4/30/2022 4/30/2022 4/30/2022 comments should be identified with the OMB control number 0910–0812. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations, Food and Drug Administration, Three White Flint North, 10A–12M, 11601 Landsdown St., North Bethesda, MD 20852, 301–796–5733, PRAStaff@ fda.hhs.gov. In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. SUPPLEMENTARY INFORMATION: E:\FR\FM\11JNN1.SGM 11JNN1

Agencies

[Federal Register Volume 84, Number 112 (Tuesday, June 11, 2019)]
[Notices]
[Page 27131]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12278]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2018-N-0215; FDA-2012-N-0248; FDA-2015-N-2126; FDA-
2012-N-0280; FDA-2012-N-1093; FDA-2018-N-4130; and FDA-2011-N-0143]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of 
information collections that have been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-7726, 
[email protected].

SUPPLEMENTARY INFORMATION: The following is a list of FDA information 
collections recently approved by OMB under section 3507 of the 
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control 
number and expiration date of OMB approval for each information 
collection are shown in table 1. Copies of the supporting statements 
for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.

        Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
                                            OMB control    Date approval
           Title of collection                  No.           expires
------------------------------------------------------------------------
Healthcare Professional Survey of              0910-0869       4/30/2020
 Professional Prescription Drug
 Promotion..............................
Formal Dispute Resolutions; Appeals            0910-0430       3/31/2022
 Above the Division Level...............
Food and Drug Administration's Research        0910-0808       3/31/2022
 and Evaluation Survey for the Public
 Education Campaign on Tobacco Among
 LGBT (RESPECT).........................
Financial Disclosure by Clinical               0910-0396       4/30/2022
 Investigators..........................
Food Additive Petitions and                    0910-0546       4/30/2022
 Investigational Food Additive
 Exemptions.............................
Recordkeeping Requirements for                 0910-0658       4/30/2022
 Microbiological Testing and Corrective
 Measures for Bottled Water.............
Foreign Supplier Verification Programs         0910-0752       4/30/2022
 for Importers of Food for Humans and
 Animals................................
------------------------------------------------------------------------


    Dated: June 6, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-12278 Filed 6-10-19; 8:45 am]
BILLING CODE 4164-01-P